This disruption can impair the hepcidin-TFR2 interaction, compromise hepatic iron sensing, and lead to increased systemic iron accumulation alongside an insufficient hepcidin response [23,24], which in turn contributes to the development of the MetS. Here, HAMP is linked to metabolic syndrome.